Medicare AdvantageCoverageMedium impact
MA11.107f, Steroid-Eluting Sinus Stents and Implants
Independence Blue Cross·ENT (Ear, Nose & Throat)·Medical Policy
Effective date
Apr 2, 2025
We identified it
Jun 19, 2026
Summary
Medicare Advantage policy MA11.107f regarding Steroid-Eluting Sinus Stents and Implants has been reissued with updates effective April 2, 2025. This policy change affects coverage or billing requirements for sinus stent procedures under Medicare Advantage plans.
Action Required
By April 2, 2025: Billing team must review the full policy MA11.107f at the source URL to identify specific changes to coverage, prior authorization, or documentation requirements for steroid-eluting sinus stents and implants. Update billing procedures and encounter forms accordingly for Medicare Advantage patients requiring sinus stent procedures.